(Q54616742)

1 June 2018

title

Clinicopathological significance and prognostic value of CD133 expression in triple-negative breast carcinoma. (English)

1 reference

1 June 2018

author name string

Po Zhao

1

1 reference

1 June 2018

Yali Lu

2

1 reference

1 June 2018

Xuege Jiang

3

1 reference

1 June 2018

Xiaoying Li

4

1 reference

1 June 2018

publication date

28 February 2011

1 reference

1 June 2018

published in

Cancer Science

1 reference

1 June 2018

volume

102

1 reference

1 June 2018

issue

5

1 reference

1 June 2018

page(s)

1107-1111

1 reference

1 June 2018

Molecular portraits of human breast tumours

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01894.X

Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01894.X

High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01894.X

Repeated observation of breast tumor subtypes in independent gene expression data sets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01894.X

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01894.X

Steroid hormone receptor status of mouse mammary stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01894.X

CD133 positive endothelial progenitor cells contribute to the tumour vasculature in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01894.X

Identification of human brain tumour initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01894.X

CD133, one of the markers of cancer stem cells in Hep-2 cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01894.X

Prospective identification of tumorigenic breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01894.X

A human colon cancer cell capable of initiating tumour growth in immunodeficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01894.X

Identification and expansion of human colon-cancer-initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01894.X

Organotypic distribution of stem cell markers in formalin-fixed brain harboring glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01894.X

Intratumoral expression level of epidermal growth factor receptor and cytokeratin 5/6 is significantly associated with nodal and distant metastases in patients with basal-like triple-negative breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01894.X

14-3-3sigma expression is an independent prognostic parameter for poor survival in colorectal carcinoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01894.X

Expression of the "stem cell marker" CD133 in pancreas and pancreatic ductal adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01894.X

Expression and clinical significance of stem cell marker CD133 in human neuroblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01894.X

Impact of American Society of Clinical Oncology/College of American Pathologists guideline recommendations on HER2 interpretation in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01894.X

10.1111/J.1349-7006.2011.01894.X

21 January 2018

Identifiers

DOI

1 reference

1 June 2018

1 reference

1 June 2018